Skip to main content
. Author manuscript; available in PMC: 2022 May 1.
Published in final edited form as: Curr Opin Cardiol. 2021 May 1;36(3):309–317. doi: 10.1097/HCO.0000000000000841

Table 1:

Common gene variants associated with hereditary ATTR amyloidosis

Val122Ile Thr60Ala Val30Met IIe68Leu Leu111Met
Prevalence 3–4% of African Americans 1% North-west Republic of Ireland Most common world-wide mutation, varies depending on country, can approach 1:1000 in endemic areas Unknown Unknown
Presenting age (median) >65 years >60 years 30–40 years in endemic areas, 50–60 years in non-endemic areas. >60 years >30 years
Male: Female 3:1 unknown 2:1 Male predominance in affected patients, but not in mutation carriers unknown
Ethnicity African/Afro-Caribbean Caucasian Any Caucasian Danish
Geographical distribution USA, Caribbean, Africa USA, Ireland, Germany, England Sweden, France, Portugal, Japan Central-northern Italy Denmark
Cardiac Phenotype Cardiac involvement always present Cardiac involvement in 42% of patients Cardiac involvement is rare, more in late-onset cases (conduction disease more common) Cardiac involvement nearly always present Cardiac involvement always present
Extra-cardiac manifestations PN (10%) and CTS AN is common, PN is less common PN and AN are common CTS is common (42%), PN is less common (<10%) CTS is common

AN, autonomic neuropathy; CM, cardiomyopathy; CTS, carpal tunnel syndrome; PN, peripheral neuropathy; THAOS, Transthyretin Amyloid Outcome Survey.